FDA Approved: NERLYNX — Supplemental Application (Puma Biotechnology, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Nerlynx (neratinib) from Puma Biotechnology, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nerlynx (neratinib)

Snippet

SUPPL AP for NERLYNX (NERATINIB)